Global Organ-on-Chip Market By Offerings (Products, Software, Services); By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Skin-on-Chip, Blood-Brain-Barrier-on-Chip, Multi-organs-on-a-chip, Others); By Application (Toxicology Research, Drug Discovery, Molecular Biology, Disease Modelling, Food Safety and Quality Testing, Others); By End-User (Biopharmaceutical Companies, Academics and Research Institutes, Food & Beverages, Cosmetics, Others); By Type of Material (Polymer, Polydimethylsiloxane, Glass, Silicon, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global organ-on-chip market was valued at US$ 29.65 Mn in 2021, growing at an estimated CAGR of 38.9% over the forecast period (2022 – 2030). Pharmaceutical companies in today’s times are suffering from major losses courtesy of limitations of existing planar along with static cell culture systems. Also there are still several diseases that haven’t been correctly modelled in vitro, and all of this is directly contributing to the growth of the organ-on-chip market. These organ-on-chips are basically smaller chips that have living cells that copy or mimic several body processes like breathing and infections. These chips are manufactured by the computer chip makers. The organ-on-chip market saw a drop in the number of sales due to the dreadful COVID-19 pandemic. The collapsed global health infrastructure and economic shutdown courtesy of curbs imposed to curtail the spread of the virus dented the growth of this market. Though experts claim that it will rise back to pre-pandemic levels very soon.
Offerings Outlook
On the basis of offerings, the organ-on-chip market has been divided into products, software and services. The product segment which has lots of variety dominates in terms of market share. Rise in chronic diseases resulting in failure of several body parts is automatically creating a demand for organs-on-chip. As these products have been successful in mimicking the actual body organs, they are being preferred by many.
Global Organ-on-Chip MarketRevenue & Forecast, (US$ Million), 2022 – 2030
Organ Type Outlook
On the basis of organ type, the organ-on-chip market has been segregated into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain-barrier-on-chip, multi-organs-on-a-chip and others. These artificial organs or chips have proven to be boon for mankind. They are being extensively used in patients suffering from serious diseases like Parkinson’s.
Application Outlook
The application segment of the organ-on-chip market has been bifurcated into toxicology research, drug discovery, disease modelling, molecular biology, food safety and quality testing and others. The drug discovery segment generates majority of the revenue for this market. These devices aid primarily in evaluation of safety of drugs before initiation of clinical trials. The use of organ-on-chip devices provide better results than vitro preclinical testing methods.
End-user Outlook
The end-user segment of the organ-on-chip market has been divided into biopharmaceutical companies, academics and research institutes, food & beverages, cosmetics, and others. Thanks to its ability to mimic human body processes, the academics and research institutes account for majority of the revenue generated by this market. As these organ-on-chip devices are proving extremely helpful in determining the efficacy and safety of new drugs prior to their entry in clinical trials, they also aid in new research.
Type of Material
On the basis of material type, the organ-on-chip market has segregated into polymer, polydimethylsiloxane (PDMS), glass, silicon, others. The polydimethylsiloxane material accounts for most of the revenue generated by this market. This is primarily because the PDMS is used for making organ-on-chips because it happens to be biocompatible, gas permeable along with being optically transparent and highly elastic.
Region Outlook
On the basis of region, the organ-on-chip market has been divided into Latin America, Europe, North America, Asia-Pacific, Middle East & Africa. The region of North America the organ-on-chip market dominates in terms of market share. Presence of leading medical research companies and more pumping of funds contributes to the growth of this market in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global organ-on-chip market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global organ-on-chip market are listed below:
- AxoSim Inc.
- BEOnChip
- BiomimX S.r.l
- CN Bio Innovations
- Elveflow
- Emulate Inc.
- InSphero AG
- Mesobiotech
- Micronit
- Mimetas BV
- Nortis Inc.
- Tara Biosystems
- TissUse GmbH
- Other Market Participants
Global Organ-on-Chip Market
By Offerings
- Products
- Software
- Services
By Organ Type
- Heart-on-chip
- Lung-on-chip
- Liver-on-chip
- Intestine-on-chip
- Kidney-on-chip
- Skin-on-chip
- Blood-Brain-Barrier-On-Chip
- Multi-organs-on-chip
- Others
By Application
- Toxicology Research
- Molecular Biology
- Disease Modelling
- Food Safety and Quality Testing
- Others
By End-user
- Biopharmaceutical Companies
- Academics and Research Institutes
- Food & Beverages
- Cosmetics
- Others
By Type of Material
- Polymer
- Polydimethylsiloxane
- Glass
- Silicon
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Base Year: 2021
1.2.2. Forecast Years: 2022 - 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Organ On-Chip Market
6.
Market
Synopsis: Organ On-Chip Market
7.
Organ
On-Chip Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Organ On-Chip Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Organ On-Chip Market
7.6. Impact of Covid-19 on Organ On-Chip Market
8.
Global
Organ On-Chip Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Organ On-Chip Market Revenue (US$ Mn)
8.2. Global Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Offerings
8.2.1. Products
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2. Software
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.2.3. Services
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2021
8.2.3.3.
Market
Forecast, 2022 - 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2021
8.2.3.5.1.2. Market Forecast, 2022 - 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2021
8.2.3.5.2.2. Market Forecast, 2022 - 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2021
8.2.3.5.3.2. Market Forecast, 2022 - 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2021
8.2.3.5.4.2. Market Forecast, 2022 - 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2021
8.2.3.5.5.2. Market Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Offerings
9.
Global
Organ On-Chip Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Organ Type
9.2.1. Lung-On-Chip
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2. Heart-On-Chip
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3. Liver-On-Chip
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.2.4. Intestine-On-Chip
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2021
9.2.4.3.
Market
Forecast, 2022 - 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2021
9.2.4.5.1.2. Market Forecast, 2022 - 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2021
9.2.4.5.2.2. Market Forecast, 2022 - 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2021
9.2.4.5.3.2. Market Forecast, 2022 - 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2021
9.2.4.5.4.2. Market Forecast, 2022 - 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2021
9.2.4.5.5.2. Market Forecast, 2022 - 2030
9.2.5. Kidney-On-Chip
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2021
9.2.5.3.
Market
Forecast, 2022 - 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2021
9.2.5.5.1.2. Market Forecast, 2022 - 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2021
9.2.5.5.2.2. Market Forecast, 2022 - 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2021
9.2.5.5.3.2. Market Forecast, 2022 - 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2021
9.2.5.5.4.2. Market Forecast, 2022 - 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2021
9.2.5.5.5.2. Market Forecast, 2022 - 2030
9.2.6. Skin-On-Chip
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2021
9.2.6.3.
Market
Forecast, 2022 - 2030
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2021
9.2.6.5.1.2. Market Forecast, 2022 - 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2021
9.2.6.5.2.2. Market Forecast, 2022 - 2030
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2021
9.2.6.5.3.2. Market Forecast, 2022 - 2030
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2021
9.2.6.5.4.2. Market Forecast, 2022 - 2030
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2021
9.2.6.5.5.2. Market Forecast, 2022 - 2030
9.2.7. Blood-Brain-Barrier-On-Chip
9.2.7.1.
Definition
9.2.7.2.
Market
Estimation and Penetration, 2021
9.2.7.3.
Market
Forecast, 2022 - 2030
9.2.7.4.
Compound
Annual Growth Rate (CAGR)
9.2.7.5.
Regional
Bifurcation
9.2.7.5.1.
North
America
9.2.7.5.1.1. Market Estimation, 2021
9.2.7.5.1.2. Market Forecast, 2022 - 2030
9.2.7.5.2.
Europe
9.2.7.5.2.1. Market Estimation, 2021
9.2.7.5.2.2. Market Forecast, 2022 - 2030
9.2.7.5.3.
Asia
Pacific
9.2.7.5.3.1. Market Estimation, 2021
9.2.7.5.3.2. Market Forecast, 2022 - 2030
9.2.7.5.4.
Middle
East and Africa
9.2.7.5.4.1. Market Estimation, 2021
9.2.7.5.4.2. Market Forecast, 2022 - 2030
9.2.7.5.5.
Latin
America
9.2.7.5.5.1. Market Estimation, 2021
9.2.7.5.5.2. Market Forecast, 2022 - 2030
9.2.8. Multi-organs-on-a-chip
9.2.8.1.
Definition
9.2.8.2.
Market
Estimation and Penetration, 2021
9.2.8.3.
Market
Forecast, 2022 - 2030
9.2.8.4.
Compound
Annual Growth Rate (CAGR)
9.2.8.5.
Regional
Bifurcation
9.2.8.5.1.
North
America
9.2.8.5.1.1. Market Estimation, 2021
9.2.8.5.1.2. Market Forecast, 2022 - 2030
9.2.8.5.2.
Europe
9.2.8.5.2.1. Market Estimation, 2021
9.2.8.5.2.2. Market Forecast, 2022 - 2030
9.2.8.5.3.
Asia
Pacific
9.2.8.5.3.1. Market Estimation, 2021
9.2.8.5.3.2. Market Forecast, 2022 - 2030
9.2.8.5.4.
Middle
East and Africa
9.2.8.5.4.1. Market Estimation, 2021
9.2.8.5.4.2. Market Forecast, 2022 - 2030
9.2.8.5.5.
Latin
America
9.2.8.5.5.1. Market Estimation, 2021
9.2.8.5.5.2. Market Forecast, 2022 - 2030
9.2.9. Others
9.2.9.1.
Definition
9.2.9.2.
Market
Estimation and Penetration, 2021
9.2.9.3.
Market
Forecast, 2022 - 2030
9.2.9.4.
Compound
Annual Growth Rate (CAGR)
9.2.9.5.
Regional
Bifurcation
9.2.9.5.1.
North
America
9.2.9.5.1.1. Market Estimation, 2021
9.2.9.5.1.2. Market Forecast, 2022 - 2030
9.2.9.5.2.
Europe
9.2.9.5.2.1. Market Estimation, 2021
9.2.9.5.2.2. Market Forecast, 2022 - 2030
9.2.9.5.3.
Asia
Pacific
9.2.9.5.3.1. Market Estimation, 2021
9.2.9.5.3.2. Market Forecast, 2022 - 2030
9.2.9.5.4.
Middle
East and Africa
9.2.9.5.4.1. Market Estimation, 2021
9.2.9.5.4.2. Market Forecast, 2022 - 2030
9.2.9.5.5.
Latin
America
9.2.9.5.5.1. Market Estimation, 2021
9.2.9.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Organ Type
10. Global Organ On-Chip Market Analysis and
Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Application
10.2.1. Toxicology Research
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Drug Discovery
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Molecular Biology
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Disease Modelling
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2021
10.2.4.3.
Market
Forecast, 2022 - 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.2.5. Food Safety and Quality Testing
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2021
10.2.5.3.
Market
Forecast, 2022 - 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2021
10.2.5.5.1.2. Market Forecast, 2022 - 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2021
10.2.5.5.2.2. Market Forecast, 2022 - 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2021
10.2.5.5.3.2. Market Forecast, 2022 - 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2021
10.2.5.5.4.2. Market Forecast, 2022 - 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2021
10.2.5.5.5.2. Market Forecast, 2022 - 2030
10.2.6. Others
10.2.6.1.
Definition
10.2.6.2.
Market
Estimation and Penetration, 2021
10.2.6.3.
Market
Forecast, 2022 - 2030
10.2.6.4.
Compound
Annual Growth Rate (CAGR)
10.2.6.5.
Regional
Bifurcation
10.2.6.5.1.
North
America
10.2.6.5.1.1. Market Estimation, 2021
10.2.6.5.1.2. Market Forecast, 2022 - 2030
10.2.6.5.2.
Europe
10.2.6.5.2.1. Market Estimation, 2021
10.2.6.5.2.2. Market Forecast, 2022 - 2030
10.2.6.5.3.
Asia
Pacific
10.2.6.5.3.1. Market Estimation, 2021
10.2.6.5.3.2. Market Forecast, 2022 - 2030
10.2.6.5.4.
Middle
East and Africa
10.2.6.5.4.1. Market Estimation, 2021
10.2.6.5.4.2. Market Forecast, 2022 - 2030
10.2.6.5.5.
Latin
America
10.2.6.5.5.1. Market Estimation, 2021
10.2.6.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Organ On-Chip Market Analysis and
Forecasts, 2022 - 2030
11.1. Overview
11.2. Global Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By End-User
11.2.1. Biopharmaceutical Companies
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2021
11.2.1.3.
Market
Forecast, 2022 - 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2021
11.2.1.5.1.2. Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2021
11.2.1.5.2.2. Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2021
11.2.1.5.3.2. Market Forecast, 2022 - 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2021
11.2.1.5.4.2. Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2021
11.2.1.5.5.2. Market Forecast, 2022 - 2030
11.2.2. Academics and Research Institutes
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2021
11.2.2.3.
Market
Forecast, 2022 - 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2021
11.2.2.5.1.2. Market Forecast, 2022 - 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2021
11.2.2.5.2.2. Market Forecast, 2022 - 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2021
11.2.2.5.3.2. Market Forecast, 2022 - 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2021
11.2.2.5.4.2. Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2021
11.2.2.5.5.2. Market Forecast, 2022 - 2030
11.2.3. Food and Beverages
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2021
11.2.3.3.
Market
Forecast, 2022 - 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2021
11.2.3.5.1.2. Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2021
11.2.3.5.2.2. Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2021
11.2.3.5.3.2. Market Forecast, 2022 - 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2021
11.2.3.5.4.2. Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2021
11.2.3.5.5.2. Market Forecast, 2022 - 2030
11.2.4. Cosmetics
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2021
11.2.4.3.
Market
Forecast, 2022 - 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2021
11.2.4.5.1.2. Market Forecast, 2022 - 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2021
11.2.4.5.2.2. Market Forecast, 2022 - 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2021
11.2.4.5.3.2. Market Forecast, 2022 - 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2021
11.2.4.5.4.2. Market Forecast, 2022 - 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2021
11.2.4.5.5.2. Market Forecast, 2022 - 2030
11.2.5. Others
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2021
11.2.5.3.
Market
Forecast, 2022 - 2030
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2021
11.2.5.5.1.2. Market Forecast, 2022 - 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2021
11.2.5.5.2.2. Market Forecast, 2022 - 2030
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2021
11.2.5.5.3.2. Market Forecast, 2022 - 2030
11.2.5.5.4.
Middle East
and Africa
11.2.5.5.4.1. Market Estimation, 2021
11.2.5.5.4.2. Market Forecast, 2022 - 2030
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2021
11.2.5.5.5.2. Market Forecast, 2022 - 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End-User
12. Global Organ On-Chip Market Analysis and
Forecasts, 2022 - 2030
12.1. Overview
12.2. Global Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Type Of Material
12.2.1. Polymer
12.2.1.1.
Definition
12.2.1.2.
Market
Estimation and Penetration, 2021
12.2.1.3.
Market
Forecast, 2022 - 2030
12.2.1.4.
Compound
Annual Growth Rate (CAGR)
12.2.1.5.
Regional
Bifurcation
12.2.1.5.1.
North
America
12.2.1.5.1.1. Market Estimation, 2021
12.2.1.5.1.2. Market Forecast, 2022 - 2030
12.2.1.5.2.
Europe
12.2.1.5.2.1. Market Estimation, 2021
12.2.1.5.2.2. Market Forecast, 2022 - 2030
12.2.1.5.3.
Asia
Pacific
12.2.1.5.3.1. Market Estimation, 2021
12.2.1.5.3.2. Market Forecast, 2022 - 2030
12.2.1.5.4.
Middle
East and Africa
12.2.1.5.4.1. Market Estimation, 2021
12.2.1.5.4.2. Market Forecast, 2022 - 2030
12.2.1.5.5.
Latin
America
12.2.1.5.5.1. Market Estimation, 2021
12.2.1.5.5.2. Market Forecast, 2022 - 2030
12.2.2. Polydimethylsiloxane (PDMS)
12.2.2.1.
Definition
12.2.2.2.
Market
Estimation and Penetration, 2021
12.2.2.3.
Market
Forecast, 2022 - 2030
12.2.2.4.
Compound
Annual Growth Rate (CAGR)
12.2.2.5.
Regional
Bifurcation
12.2.2.5.1.
North
America
12.2.2.5.1.1. Market Estimation, 2021
12.2.2.5.1.2. Market Forecast, 2022 - 2030
12.2.2.5.2.
Europe
12.2.2.5.2.1. Market Estimation, 2021
12.2.2.5.2.2. Market Forecast, 2022 - 2030
12.2.2.5.3.
Asia
Pacific
12.2.2.5.3.1. Market Estimation, 2021
12.2.2.5.3.2. Market Forecast, 2022 - 2030
12.2.2.5.4.
Middle
East and Africa
12.2.2.5.4.1. Market Estimation, 2021
12.2.2.5.4.2. Market Forecast, 2022 - 2030
12.2.2.5.5.
Latin
America
12.2.2.5.5.1. Market Estimation, 2021
12.2.2.5.5.2. Market Forecast, 2022 - 2030
12.2.3. Glass
12.2.3.1.
Definition
12.2.3.2.
Market
Estimation and Penetration, 2021
12.2.3.3.
Market
Forecast, 2022 - 2030
12.2.3.4.
Compound
Annual Growth Rate (CAGR)
12.2.3.5.
Regional
Bifurcation
12.2.3.5.1.
North
America
12.2.3.5.1.1. Market Estimation, 2021
12.2.3.5.1.2. Market Forecast, 2022 - 2030
12.2.3.5.2.
Europe
12.2.3.5.2.1. Market Estimation, 2021
12.2.3.5.2.2. Market Forecast, 2022 - 2030
12.2.3.5.3.
Asia
Pacific
12.2.3.5.3.1. Market Estimation, 2021
12.2.3.5.3.2. Market Forecast, 2022 - 2030
12.2.3.5.4.
Middle
East and Africa
12.2.3.5.4.1. Market Estimation, 2021
12.2.3.5.4.2. Market Forecast, 2022 - 2030
12.2.3.5.5.
Latin
America
12.2.3.5.5.1. Market Estimation, 2021
12.2.3.5.5.2. Market Forecast, 2022 - 2030
12.2.4. Silicon
12.2.4.1.
Definition
12.2.4.2.
Market
Estimation and Penetration, 2021
12.2.4.3.
Market
Forecast, 2022 - 2030
12.2.4.4.
Compound
Annual Growth Rate (CAGR)
12.2.4.5.
Regional
Bifurcation
12.2.4.5.1.
North
America
12.2.4.5.1.1. Market Estimation, 2021
12.2.4.5.1.2. Market Forecast, 2022 - 2030
12.2.4.5.2.
Europe
12.2.4.5.2.1. Market Estimation, 2021
12.2.4.5.2.2. Market Forecast, 2022 - 2030
12.2.4.5.3.
Asia
Pacific
12.2.4.5.3.1. Market Estimation, 2021
12.2.4.5.3.2. Market Forecast, 2022 - 2030
12.2.4.5.4.
Middle
East and Africa
12.2.4.5.4.1. Market Estimation, 2021
12.2.4.5.4.2. Market Forecast, 2022 - 2030
12.2.4.5.5.
Latin
America
12.2.4.5.5.1. Market Estimation, 2021
12.2.4.5.5.2. Market Forecast, 2022 - 2030
12.2.5. Others
12.2.5.1.
Definition
12.2.5.2.
Market
Estimation and Penetration, 2021
12.2.5.3.
Market
Forecast, 2022 - 2030
12.2.5.4.
Compound
Annual Growth Rate (CAGR)
12.2.5.5.
Regional
Bifurcation
12.2.5.5.1.
North
America
12.2.5.5.1.1. Market Estimation, 2021
12.2.5.5.1.2. Market Forecast, 2022 - 2030
12.2.5.5.2.
Europe
12.2.5.5.2.1. Market Estimation, 2021
12.2.5.5.2.2. Market Forecast, 2022 - 2030
12.2.5.5.3.
Asia
Pacific
12.2.5.5.3.1. Market Estimation, 2021
12.2.5.5.3.2. Market Forecast, 2022 - 2030
12.2.5.5.4.
Middle
East and Africa
12.2.5.5.4.1. Market Estimation, 2021
12.2.5.5.4.2. Market Forecast, 2022 - 2030
12.2.5.5.5.
Latin
America
12.2.5.5.5.1. Market Estimation, 2021
12.2.5.5.5.2. Market Forecast, 2022 - 2030
12.3. Key Segment for Channeling Investments
12.3.1. By Type Of Material
13. North America Organ On-Chip Market Analysis
and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. North America Organ On-Chip Market Revenue
(US$ Mn)
13.2. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Offerings
13.2.1. Products
13.2.2. Software
13.2.3. Services
13.3. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Organ Type
13.3.1. Lung-On-Chip
13.3.2. Heart-On-Chip
13.3.3. Liver-On-Chip
13.3.4. Intestine-On-Chip
13.3.5. Kidney-On-Chip
13.3.6. Skin-On-Chip
13.3.7. Blood-Brain-Barrier-On-Chip
13.3.8. Multi-organs-on-a-chip
13.3.9. Others
13.4. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.1. Toxicology Research
13.4.2. Drug Discovery
13.4.3. Molecular Biology
13.4.4. Disease Modelling
13.4.5. Food Safety and Quality Testing
13.4.6. Others
13.5. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By End-User
13.5.1. Biopharmaceutical Companies
13.5.2. Academics and Research Institutes
13.5.3. Food and Beverages
13.5.4. Cosmetics
13.5.5. Others
13.6. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Type Of Material
13.6.1. Polymer
13.6.2. Polydimethylsiloxane (PDMS)
13.6.3. Glass
13.6.4. Silicon
13.6.5. Others
13.7. North America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1.
U.S
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
13.7.1.1.1.
Products
13.7.1.1.2.
Software
13.7.1.1.3.
Services
13.7.1.2.
U.S
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
13.7.1.2.1.
Lung-On-Chip
13.7.1.2.2.
Heart-On-Chip
13.7.1.2.3.
Liver-On-Chip
13.7.1.2.4.
Intestine-On-Chip
13.7.1.2.5.
Kidney-On-Chip
13.7.1.2.6.
Skin-On-Chip
13.7.1.2.7.
Blood-Brain-Barrier-On-Chip
13.7.1.2.8.
Multi-organs-on-a-chip
13.7.1.2.9.
Others
13.7.1.3.
U.S
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.3.1.
Toxicology
Research
13.7.1.3.2.
Drug
Discovery
13.7.1.3.3.
Molecular
Biology
13.7.1.3.4.
Disease
Modelling
13.7.1.3.5.
Food
Safety and Quality Testing
13.7.1.3.6.
Others
13.7.1.4.
U.S
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
13.7.1.4.1.
Biopharmaceutical
Companies
13.7.1.4.2.
Academics
and Research Institutes
13.7.1.4.3.
Food and
Beverages
13.7.1.4.4.
Cosmetics
13.7.1.4.5.
Others
13.7.1.5.
U.S
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
13.7.1.5.1.
Polymer
13.7.1.5.2.
Polydimethylsiloxane
(PDMS)
13.7.1.5.3.
Glass
13.7.1.5.4.
Silicon
13.7.1.5.5.
Others
13.7.2. Canada
13.7.2.1.
Canada
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
13.7.2.1.1.
Products
13.7.2.1.2.
Software
13.7.2.1.3.
Services
13.7.2.2.
Canada
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
13.7.2.2.1.
Lung-On-Chip
13.7.2.2.2.
Heart-On-Chip
13.7.2.2.3.
Liver-On-Chip
13.7.2.2.4.
Intestine-On-Chip
13.7.2.2.5.
Kidney-On-Chip
13.7.2.2.6.
Skin-On-Chip
13.7.2.2.7.
Blood-Brain-Barrier-On-Chip
13.7.2.2.8.
Multi-organs-on-a-chip
13.7.2.2.9.
Others
13.7.2.3.
Canada
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.3.1.
Toxicology
Research
13.7.2.3.2.
Drug
Discovery
13.7.2.3.3.
Molecular
Biology
13.7.2.3.4.
Disease
Modelling
13.7.2.3.5.
Food
Safety and Quality Testing
13.7.2.3.6.
Others
13.7.2.4.
Canada
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
13.7.2.4.1.
Biopharmaceutical
Companies
13.7.2.4.2.
Academics
and Research Institutes
13.7.2.4.3.
Food and
Beverages
13.7.2.4.4.
Cosmetics
13.7.2.4.5.
Others
13.7.2.5.
Canada
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
13.7.2.5.1.
Polymer
13.7.2.5.2.
Polydimethylsiloxane
(PDMS)
13.7.2.5.3.
Glass
13.7.2.5.4.
Silicon
13.7.2.5.5.
Others
13.7.3. Mexico
13.7.3.1.
Mexico
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
13.7.3.1.1.
Products
13.7.3.1.2.
Software
13.7.3.1.3.
Services
13.7.3.2.
Mexico
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
13.7.3.2.1.
Lung-On-Chip
13.7.3.2.2.
Heart-On-Chip
13.7.3.2.3.
Liver-On-Chip
13.7.3.2.4.
Intestine-On-Chip
13.7.3.2.5.
Kidney-On-Chip
13.7.3.2.6.
Skin-On-Chip
13.7.3.2.7.
Blood-Brain-Barrier-On-Chip
13.7.3.2.8.
Multi-organs-on-a-chip
13.7.3.2.9.
Others
13.7.3.3.
Mexico
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.3.1.
Toxicology
Research
13.7.3.3.2.
Drug
Discovery
13.7.3.3.3.
Molecular
Biology
13.7.3.3.4.
Disease
Modelling
13.7.3.3.5.
Food
Safety and Quality Testing
13.7.3.3.6.
Others
13.7.3.4.
Mexico Organ
On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
13.7.3.4.1.
Biopharmaceutical
Companies
13.7.3.4.2.
Academics
and Research Institutes
13.7.3.4.3.
Food and
Beverages
13.7.3.4.4.
Cosmetics
13.7.3.4.5.
Others
13.7.3.5.
Mexico
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
13.7.3.5.1.
Polymer
13.7.3.5.2.
Polydimethylsiloxane
(PDMS)
13.7.3.5.3.
Glass
13.7.3.5.4.
Silicon
13.7.3.5.5.
Others
13.7.4. Rest of North America
13.7.4.1.
Rest of
North America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
13.7.4.1.1.
Products
13.7.4.1.2.
Software
13.7.4.1.3.
Services
13.7.4.2.
Rest of
North America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ
Type
13.7.4.2.1.
Lung-On-Chip
13.7.4.2.2.
Heart-On-Chip
13.7.4.2.3.
Liver-On-Chip
13.7.4.2.4.
Intestine-On-Chip
13.7.4.2.5.
Kidney-On-Chip
13.7.4.2.6.
Skin-On-Chip
13.7.4.2.7.
Blood-Brain-Barrier-On-Chip
13.7.4.2.8.
Multi-organs-on-a-chip
13.7.4.2.9.
Others
13.7.4.3.
Rest of
North America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.3.1.
Toxicology
Research
13.7.4.3.2.
Drug
Discovery
13.7.4.3.3.
Molecular
Biology
13.7.4.3.4.
Disease
Modelling
13.7.4.3.5.
Food
Safety and Quality Testing
13.7.4.3.6.
Others
13.7.4.4.
Rest of
North America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
13.7.4.4.1.
Biopharmaceutical
Companies
13.7.4.4.2.
Academics
and Research Institutes
13.7.4.4.3.
Food and
Beverages
13.7.4.4.4.
Cosmetics
13.7.4.4.5.
Others
13.7.4.5.
Rest of
North America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of
Material
13.7.4.5.1.
Polymer
13.7.4.5.2.
Polydimethylsiloxane
(PDMS)
13.7.4.5.3.
Glass
13.7.4.5.4.
Silicon
13.7.4.5.5.
Others
13.8. Key Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Offerings
13.8.3. By Organ Type
13.8.4. By Application
13.8.5. By End-User
13.8.6. By Type Of Material
14. Europe Organ On-Chip Market Analysis and
Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Europe Organ On-Chip Market Revenue (US$ Mn)
14.2. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.2.1. Products
14.2.2. Software
14.2.3. Services
14.3. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Organ Type
14.3.1. Lung-On-Chip
14.3.2. Heart-On-Chip
14.3.3. Liver-On-Chip
14.3.4. Intestine-On-Chip
14.3.5. Kidney-On-Chip
14.3.6. Skin-On-Chip
14.3.7. Blood-Brain-Barrier-On-Chip
14.3.8. Multi-organs-on-a-chip
14.3.9. Others
14.4. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.1. Toxicology Research
14.4.2. Drug Discovery
14.4.3. Molecular Biology
14.4.4. Disease Modelling
14.4.5. Food Safety and Quality Testing
14.4.6. Others
14.5. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By End-User
14.5.1. Biopharmaceutical Companies
14.5.2. Academics and Research Institutes
14.5.3. Food and Beverages
14.5.4. Cosmetics
14.5.5. Others
14.6. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Type Of Material
14.6.1. Polymer
14.6.2. Polydimethylsiloxane (PDMS)
14.6.3. Glass
14.6.4. Silicon
14.6.5. Others
14.7. Europe Organ On-Chip Market Revenue (US$ Mn)
and Forecasts, By Country
14.7.1. France
14.7.1.1.
France
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.1.1.1.
Products
14.7.1.1.2.
Software
14.7.1.1.3.
Services
14.7.1.2.
France
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.1.2.1.
Lung-On-Chip
14.7.1.2.2.
Heart-On-Chip
14.7.1.2.3.
Liver-On-Chip
14.7.1.2.4.
Intestine-On-Chip
14.7.1.2.5.
Kidney-On-Chip
14.7.1.2.6.
Skin-On-Chip
14.7.1.2.7.
Blood-Brain-Barrier-On-Chip
14.7.1.2.8.
Multi-organs-on-a-chip
14.7.1.2.9.
Others
14.7.1.3.
France
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.3.1.
Toxicology
Research
14.7.1.3.2.
Drug
Discovery
14.7.1.3.3.
Molecular
Biology
14.7.1.3.4.
Disease
Modelling
14.7.1.3.5.
Food
Safety and Quality Testing
14.7.1.3.6.
Others
14.7.1.4.
France
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.1.4.1.
Biopharmaceutical
Companies
14.7.1.4.2.
Academics
and Research Institutes
14.7.1.4.3.
Food and
Beverages
14.7.1.4.4.
Cosmetics
14.7.1.4.5.
Others
14.7.1.5.
France
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.1.5.1.
Polymer
14.7.1.5.2.
Polydimethylsiloxane
(PDMS)
14.7.1.5.3.
Glass
14.7.1.5.4.
Silicon
14.7.1.5.5.
Others
14.7.2. The UK
14.7.2.1.
The UK
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.2.1.1.
Products
14.7.2.1.2.
Software
14.7.2.1.3.
Services
14.7.2.2.
The UK
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.2.2.1.
Lung-On-Chip
14.7.2.2.2.
Heart-On-Chip
14.7.2.2.3.
Liver-On-Chip
14.7.2.2.4.
Intestine-On-Chip
14.7.2.2.5.
Kidney-On-Chip
14.7.2.2.6.
Skin-On-Chip
14.7.2.2.7.
Blood-Brain-Barrier-On-Chip
14.7.2.2.8.
Multi-organs-on-a-chip
14.7.2.2.9.
Others
14.7.2.3.
The UK
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.3.1.
Toxicology
Research
14.7.2.3.2.
Drug
Discovery
14.7.2.3.3.
Molecular
Biology
14.7.2.3.4.
Disease
Modelling
14.7.2.3.5.
Food
Safety and Quality Testing
14.7.2.3.6.
Others
14.7.2.4.
The UK
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.2.4.1.
Biopharmaceutical
Companies
14.7.2.4.2.
Academics
and Research Institutes
14.7.2.4.3.
Food and
Beverages
14.7.2.4.4.
Cosmetics
14.7.2.4.5.
Others
14.7.2.5.
The UK
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.2.5.1.
Polymer
14.7.2.5.2.
Polydimethylsiloxane
(PDMS)
14.7.2.5.3.
Glass
14.7.2.5.4.
Silicon
14.7.2.5.5.
Others
14.7.3. Spain
14.7.3.1.
Spain
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.3.1.1.
Products
14.7.3.1.2.
Software
14.7.3.1.3.
Services
14.7.3.2.
Spain
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.3.2.1.
Lung-On-Chip
14.7.3.2.2.
Heart-On-Chip
14.7.3.2.3.
Liver-On-Chip
14.7.3.2.4.
Intestine-On-Chip
14.7.3.2.5.
Kidney-On-Chip
14.7.3.2.6.
Skin-On-Chip
14.7.3.2.7.
Blood-Brain-Barrier-On-Chip
14.7.3.2.8.
Multi-organs-on-a-chip
14.7.3.2.9.
Others
14.7.3.3.
Spain
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.3.1.
Toxicology
Research
14.7.3.3.2.
Drug
Discovery
14.7.3.3.3.
Molecular
Biology
14.7.3.3.4.
Disease
Modelling
14.7.3.3.5.
Food
Safety and Quality Testing
14.7.3.3.6.
Others
14.7.3.4.
Spain
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.3.4.1.
Biopharmaceutical
Companies
14.7.3.4.2.
Academics
and Research Institutes
14.7.3.4.3.
Food and
Beverages
14.7.3.4.4.
Cosmetics
14.7.3.4.5.
Others
14.7.3.5.
Spain
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.3.5.1.
Polymer
14.7.3.5.2.
Polydimethylsiloxane
(PDMS)
14.7.3.5.3.
Glass
14.7.3.5.4.
Silicon
14.7.3.5.5.
Others
14.7.4. Germany
14.7.4.1.
Germany
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.4.1.1.
Products
14.7.4.1.2.
Software
14.7.4.1.3.
Services
14.7.4.2.
Germany
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.4.2.1.
Lung-On-Chip
14.7.4.2.2.
Heart-On-Chip
14.7.4.2.3.
Liver-On-Chip
14.7.4.2.4.
Intestine-On-Chip
14.7.4.2.5.
Kidney-On-Chip
14.7.4.2.6.
Skin-On-Chip
14.7.4.2.7.
Blood-Brain-Barrier-On-Chip
14.7.4.2.8.
Multi-organs-on-a-chip
14.7.4.2.9.
Others
14.7.4.3.
Germany
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.3.1.
Toxicology
Research
14.7.4.3.2.
Drug
Discovery
14.7.4.3.3.
Molecular
Biology
14.7.4.3.4.
Disease
Modelling
14.7.4.3.5.
Food
Safety and Quality Testing
14.7.4.3.6.
Others
14.7.4.4.
Germany
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.4.4.1.
Biopharmaceutical
Companies
14.7.4.4.2.
Academics
and Research Institutes
14.7.4.4.3.
Food and
Beverages
14.7.4.4.4.
Cosmetics
14.7.4.4.5.
Others
14.7.4.5.
Germany
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.4.5.1.
Polymer
14.7.4.5.2.
Polydimethylsiloxane
(PDMS)
14.7.4.5.3.
Glass
14.7.4.5.4.
Silicon
14.7.4.5.5.
Others
14.7.5. Italy
14.7.5.1.
Italy
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.5.1.1.
Products
14.7.5.1.2.
Software
14.7.5.1.3.
Services
14.7.5.2.
Italy
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.5.2.1.
Lung-On-Chip
14.7.5.2.2.
Heart-On-Chip
14.7.5.2.3.
Liver-On-Chip
14.7.5.2.4.
Intestine-On-Chip
14.7.5.2.5.
Kidney-On-Chip
14.7.5.2.6.
Skin-On-Chip
14.7.5.2.7.
Blood-Brain-Barrier-On-Chip
14.7.5.2.8.
Multi-organs-on-a-chip
14.7.5.2.9.
Others
14.7.5.3.
Italy
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.3.1.
Toxicology
Research
14.7.5.3.2.
Drug
Discovery
14.7.5.3.3.
Molecular
Biology
14.7.5.3.4.
Disease
Modelling
14.7.5.3.5.
Food
Safety and Quality Testing
14.7.5.3.6.
Others
14.7.5.4.
Italy
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.5.4.1.
Biopharmaceutical
Companies
14.7.5.4.2.
Academics
and Research Institutes
14.7.5.4.3.
Food and
Beverages
14.7.5.4.4.
Cosmetics
14.7.5.4.5.
Others
14.7.5.5.
Italy Organ
On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.5.5.1.
Polymer
14.7.5.5.2.
Polydimethylsiloxane
(PDMS)
14.7.5.5.3.
Glass
14.7.5.5.4.
Silicon
14.7.5.5.5.
Others
14.7.6. Nordic Countries
14.7.6.1.
Nordic
Countries Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.6.1.1.
Products
14.7.6.1.2.
Software
14.7.6.1.3.
Services
14.7.6.2.
Nordic
Countries Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.6.2.1.
Lung-On-Chip
14.7.6.2.2.
Heart-On-Chip
14.7.6.2.3.
Liver-On-Chip
14.7.6.2.4.
Intestine-On-Chip
14.7.6.2.5.
Kidney-On-Chip
14.7.6.2.6.
Skin-On-Chip
14.7.6.2.7.
Blood-Brain-Barrier-On-Chip
14.7.6.2.8.
Multi-organs-on-a-chip
14.7.6.2.9.
Others
14.7.6.3.
Nordic
Countries Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.6.3.1.
Toxicology
Research
14.7.6.3.2.
Drug
Discovery
14.7.6.3.3.
Molecular
Biology
14.7.6.3.4.
Disease
Modelling
14.7.6.3.5.
Food
Safety and Quality Testing
14.7.6.3.6.
Others
14.7.6.4.
Nordic
Countries Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.6.4.1.
Biopharmaceutical
Companies
14.7.6.4.2.
Academics
and Research Institutes
14.7.6.4.3.
Food and
Beverages
14.7.6.4.4.
Cosmetics
14.7.6.4.5.
Others
14.7.6.5.
Nordic
Countries Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of
Material
14.7.6.5.1.
Polymer
14.7.6.5.2.
Polydimethylsiloxane
(PDMS)
14.7.6.5.3.
Glass
14.7.6.5.4.
Silicon
14.7.6.5.5.
Others
14.7.6.6.
Nordic Countries
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.
Denmark
14.7.6.6.2.
Finland
14.7.6.6.3.
Iceland
14.7.6.6.4.
Sweden
14.7.6.6.5.
Norway
14.7.7. Benelux Union
14.7.7.1.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.7.1.1.
Products
14.7.7.1.2.
Software
14.7.7.1.3.
Services
14.7.7.2.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.7.2.1.
Lung-On-Chip
14.7.7.2.2.
Heart-On-Chip
14.7.7.2.3.
Liver-On-Chip
14.7.7.2.4.
Intestine-On-Chip
14.7.7.2.5.
Kidney-On-Chip
14.7.7.2.6.
Skin-On-Chip
14.7.7.2.7.
Blood-Brain-Barrier-On-Chip
14.7.7.2.8.
Multi-organs-on-a-chip
14.7.7.2.9.
Others
14.7.7.3.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.3.1.
Toxicology
Research
14.7.7.3.2.
Drug
Discovery
14.7.7.3.3.
Molecular
Biology
14.7.7.3.4.
Disease
Modelling
14.7.7.3.5.
Food
Safety and Quality Testing
14.7.7.3.6.
Others
14.7.7.4.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.7.4.1.
Biopharmaceutical
Companies
14.7.7.4.2.
Academics
and Research Institutes
14.7.7.4.3.
Food and
Beverages
14.7.7.4.4.
Cosmetics
14.7.7.4.5.
Others
14.7.7.5.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.7.5.1.
Polymer
14.7.7.5.2.
Polydimethylsiloxane
(PDMS)
14.7.7.5.3.
Glass
14.7.7.5.4.
Silicon
14.7.7.5.5.
Others
14.7.7.6.
Benelux
Union Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.
Belgium
14.7.7.6.2.
The
Netherlands
14.7.7.6.3.
Luxembourg
14.7.8. Rest of Europe
14.7.8.1.
Rest of
Europe Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
14.7.8.1.1.
Products
14.7.8.1.2.
Software
14.7.8.1.3.
Services
14.7.8.2.
Rest of
Europe Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
14.7.8.2.1.
Lung-On-Chip
14.7.8.2.2.
Heart-On-Chip
14.7.8.2.3.
Liver-On-Chip
14.7.8.2.4.
Intestine-On-Chip
14.7.8.2.5.
Kidney-On-Chip
14.7.8.2.6.
Skin-On-Chip
14.7.8.2.7.
Blood-Brain-Barrier-On-Chip
14.7.8.2.8.
Multi-organs-on-a-chip
14.7.8.2.9.
Others
14.7.8.3.
Rest of
Europe Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.3.1.
Toxicology
Research
14.7.8.3.2.
Drug
Discovery
14.7.8.3.3.
Molecular
Biology
14.7.8.3.4.
Disease
Modelling
14.7.8.3.5.
Food
Safety and Quality Testing
14.7.8.3.6.
Others
14.7.8.4.
Rest of
Europe Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
14.7.8.4.1.
Biopharmaceutical
Companies
14.7.8.4.2.
Academics
and Research Institutes
14.7.8.4.3.
Food and
Beverages
14.7.8.4.4.
Cosmetics
14.7.8.4.5.
Others
14.7.8.5.
Rest of
Europe Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
14.7.8.5.1.
Polymer
14.7.8.5.2.
Polydimethylsiloxane
(PDMS)
14.7.8.5.3.
Glass
14.7.8.5.4.
Silicon
14.7.8.5.5.
Others
14.8. Key Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Offerings
14.8.3. By Organ Type
14.8.4. By Application
14.8.5. By End-User
14.8.6. By Type Of Material
15. Asia Pacific Organ On-Chip Market Analysis
and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn)
15.2. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Offerings
15.2.1. Products
15.2.2. Software
15.2.3. Services
15.3. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Organ Type
15.3.1. Lung-On-Chip
15.3.2. Heart-On-Chip
15.3.3. Liver-On-Chip
15.3.4. Intestine-On-Chip
15.3.5. Kidney-On-Chip
15.3.6. Skin-On-Chip
15.3.7. Blood-Brain-Barrier-On-Chip
15.3.8. Multi-organs-on-a-chip
15.3.9. Others
15.4. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Application
15.4.1. Toxicology Research
15.4.2. Drug Discovery
15.4.3. Molecular Biology
15.4.4. Disease Modelling
15.4.5. Food Safety and Quality Testing
15.4.6. Others
15.5. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By End-User
15.5.1. Biopharmaceutical Companies
15.5.2. Academics and Research Institutes
15.5.3. Food and Beverages
15.5.4. Cosmetics
15.5.5. Others
15.6. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Type Of Material
15.6.1. Polymer
15.6.2. Polydimethylsiloxane (PDMS)
15.6.3. Glass
15.6.4. Silicon
15.6.5. Others
15.7. Asia Pacific Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1.
China
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.1.1.1.
Products
15.7.1.1.2.
Software
15.7.1.1.3.
Services
15.7.1.2.
China
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.1.2.1.
Lung-On-Chip
15.7.1.2.2.
Heart-On-Chip
15.7.1.2.3.
Liver-On-Chip
15.7.1.2.4.
Intestine-On-Chip
15.7.1.2.5.
Kidney-On-Chip
15.7.1.2.6.
Skin-On-Chip
15.7.1.2.7.
Blood-Brain-Barrier-On-Chip
15.7.1.2.8.
Multi-organs-on-a-chip
15.7.1.2.9.
Others
15.7.1.3.
China
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.3.1.
Toxicology
Research
15.7.1.3.2.
Drug
Discovery
15.7.1.3.3.
Molecular
Biology
15.7.1.3.4.
Disease
Modelling
15.7.1.3.5.
Food
Safety and Quality Testing
15.7.1.3.6.
Others
15.7.1.4.
China
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.1.4.1.
Biopharmaceutical
Companies
15.7.1.4.2.
Academics
and Research Institutes
15.7.1.4.3.
Food and
Beverages
15.7.1.4.4.
Cosmetics
15.7.1.4.5.
Others
15.7.1.5.
China Organ
On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.1.5.1.
Polymer
15.7.1.5.2.
Polydimethylsiloxane
(PDMS)
15.7.1.5.3.
Glass
15.7.1.5.4.
Silicon
15.7.1.5.5.
Others
15.7.2. Japan
15.7.2.1.
Japan
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.2.1.1.
Products
15.7.2.1.2.
Software
15.7.2.1.3.
Services
15.7.2.2.
Japan
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.2.2.1.
Lung-On-Chip
15.7.2.2.2.
Heart-On-Chip
15.7.2.2.3.
Liver-On-Chip
15.7.2.2.4.
Intestine-On-Chip
15.7.2.2.5.
Kidney-On-Chip
15.7.2.2.6.
Skin-On-Chip
15.7.2.2.7.
Blood-Brain-Barrier-On-Chip
15.7.2.2.8.
Multi-organs-on-a-chip
15.7.2.2.9.
Others
15.7.2.3.
Japan
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.3.1.
Toxicology
Research
15.7.2.3.2.
Drug
Discovery
15.7.2.3.3.
Molecular
Biology
15.7.2.3.4.
Disease
Modelling
15.7.2.3.5.
Food
Safety and Quality Testing
15.7.2.3.6.
Others
15.7.2.4.
Japan
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.2.4.1.
Biopharmaceutical
Companies
15.7.2.4.2.
Academics
and Research Institutes
15.7.2.4.3.
Food and
Beverages
15.7.2.4.4.
Cosmetics
15.7.2.4.5.
Others
15.7.2.5.
Japan
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.2.5.1.
Polymer
15.7.2.5.2.
Polydimethylsiloxane
(PDMS)
15.7.2.5.3.
Glass
15.7.2.5.4.
Silicon
15.7.2.5.5.
Others
15.7.3. India
15.7.3.1.
India
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.3.1.1.
Products
15.7.3.1.2.
Software
15.7.3.1.3.
Services
15.7.3.2.
India
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.3.2.1.
Lung-On-Chip
15.7.3.2.2.
Heart-On-Chip
15.7.3.2.3.
Liver-On-Chip
15.7.3.2.4.
Intestine-On-Chip
15.7.3.2.5.
Kidney-On-Chip
15.7.3.2.6.
Skin-On-Chip
15.7.3.2.7.
Blood-Brain-Barrier-On-Chip
15.7.3.2.8.
Multi-organs-on-a-chip
15.7.3.2.9.
Others
15.7.3.3.
India
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.3.1.
Toxicology
Research
15.7.3.3.2.
Drug
Discovery
15.7.3.3.3.
Molecular
Biology
15.7.3.3.4.
Disease
Modelling
15.7.3.3.5.
Food
Safety and Quality Testing
15.7.3.3.6.
Others
15.7.3.4.
India
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.3.4.1.
Biopharmaceutical
Companies
15.7.3.4.2.
Academics
and Research Institutes
15.7.3.4.3.
Food and
Beverages
15.7.3.4.4.
Cosmetics
15.7.3.4.5.
Others
15.7.3.5.
India
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.3.5.1.
Polymer
15.7.3.5.2.
Polydimethylsiloxane
(PDMS)
15.7.3.5.3.
Glass
15.7.3.5.4.
Silicon
15.7.3.5.5.
Others
15.7.4. New Zealand
15.7.4.1.
New
Zealand Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.4.1.1.
Products
15.7.4.1.2.
Software
15.7.4.1.3.
Services
15.7.4.2.
New
Zealand Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.4.2.1.
Lung-On-Chip
15.7.4.2.2.
Heart-On-Chip
15.7.4.2.3.
Liver-On-Chip
15.7.4.2.4.
Intestine-On-Chip
15.7.4.2.5.
Kidney-On-Chip
15.7.4.2.6.
Skin-On-Chip
15.7.4.2.7.
Blood-Brain-Barrier-On-Chip
15.7.4.2.8.
Multi-organs-on-a-chip
15.7.4.2.9.
Others
15.7.4.3.
New
Zealand Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.3.1.
Toxicology
Research
15.7.4.3.2.
Drug
Discovery
15.7.4.3.3.
Molecular
Biology
15.7.4.3.4.
Disease
Modelling
15.7.4.3.5.
Food
Safety and Quality Testing
15.7.4.3.6.
Others
15.7.4.4.
New
Zealand Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.4.4.1.
Biopharmaceutical
Companies
15.7.4.4.2.
Academics
and Research Institutes
15.7.4.4.3.
Food and
Beverages
15.7.4.4.4.
Cosmetics
15.7.4.4.5.
Others
15.7.4.5.
New
Zealand Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of
Material
15.7.4.5.1.
Polymer
15.7.4.5.2.
Polydimethylsiloxane
(PDMS)
15.7.4.5.3.
Glass
15.7.4.5.4.
Silicon
15.7.4.5.5.
Others
15.7.5. Australia
15.7.5.1.
Australia
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.5.1.1.
Products
15.7.5.1.2.
Software
15.7.5.1.3.
Services
15.7.5.2.
Australia
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.5.2.1.
Lung-On-Chip
15.7.5.2.2.
Heart-On-Chip
15.7.5.2.3.
Liver-On-Chip
15.7.5.2.4.
Intestine-On-Chip
15.7.5.2.5.
Kidney-On-Chip
15.7.5.2.6.
Skin-On-Chip
15.7.5.2.7.
Blood-Brain-Barrier-On-Chip
15.7.5.2.8.
Multi-organs-on-a-chip
15.7.5.2.9.
Others
15.7.5.3.
Australia
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.3.1.
Toxicology
Research
15.7.5.3.2.
Drug
Discovery
15.7.5.3.3.
Molecular
Biology
15.7.5.3.4.
Disease
Modelling
15.7.5.3.5.
Food
Safety and Quality Testing
15.7.5.3.6.
Others
15.7.5.4.
Australia
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.5.4.1.
Biopharmaceutical
Companies
15.7.5.4.2.
Academics
and Research Institutes
15.7.5.4.3.
Food and
Beverages
15.7.5.4.4.
Cosmetics
15.7.5.4.5.
Others
15.7.5.5.
Australia
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.5.5.1.
Polymer
15.7.5.5.2.
Polydimethylsiloxane
(PDMS)
15.7.5.5.3.
Glass
15.7.5.5.4.
Silicon
15.7.5.5.5.
Others
15.7.6. South Korea
15.7.6.1.
South
Korea Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.6.1.1.
Products
15.7.6.1.2.
Software
15.7.6.1.3.
Services
15.7.6.2.
South
Korea Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.6.2.1.
Lung-On-Chip
15.7.6.2.2.
Heart-On-Chip
15.7.6.2.3.
Liver-On-Chip
15.7.6.2.4.
Intestine-On-Chip
15.7.6.2.5.
Kidney-On-Chip
15.7.6.2.6.
Skin-On-Chip
15.7.6.2.7.
Blood-Brain-Barrier-On-Chip
15.7.6.2.8.
Multi-organs-on-a-chip
15.7.6.2.9.
Others
15.7.6.3.
South
Korea Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.3.1.
Toxicology
Research
15.7.6.3.2.
Drug
Discovery
15.7.6.3.3.
Molecular
Biology
15.7.6.3.4.
Disease
Modelling
15.7.6.3.5.
Food
Safety and Quality Testing
15.7.6.3.6.
Others
15.7.6.4.
South
Korea Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.6.4.1.
Biopharmaceutical
Companies
15.7.6.4.2.
Academics
and Research Institutes
15.7.6.4.3.
Food and
Beverages
15.7.6.4.4.
Cosmetics
15.7.6.4.5.
Others
15.7.6.5.
South
Korea Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.6.5.1.
Polymer
15.7.6.5.2.
Polydimethylsiloxane
(PDMS)
15.7.6.5.3.
Glass
15.7.6.5.4.
Silicon
15.7.6.5.5.
Others
15.7.7. Southeast Asia
15.7.7.1.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.7.1.1.
Products
15.7.7.1.2.
Software
15.7.7.1.3.
Services
15.7.7.2.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.7.2.1.
Lung-On-Chip
15.7.7.2.2.
Heart-On-Chip
15.7.7.2.3.
Liver-On-Chip
15.7.7.2.4.
Intestine-On-Chip
15.7.7.2.5.
Kidney-On-Chip
15.7.7.2.6.
Skin-On-Chip
15.7.7.2.7.
Blood-Brain-Barrier-On-Chip
15.7.7.2.8.
Multi-organs-on-a-chip
15.7.7.2.9.
Others
15.7.7.3.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.3.1.
Toxicology
Research
15.7.7.3.2.
Drug
Discovery
15.7.7.3.3.
Molecular
Biology
15.7.7.3.4.
Disease
Modelling
15.7.7.3.5.
Food
Safety and Quality Testing
15.7.7.3.6.
Others
15.7.7.4.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.7.4.1.
Biopharmaceutical
Companies
15.7.7.4.2.
Academics
and Research Institutes
15.7.7.4.3.
Food and
Beverages
15.7.7.4.4.
Cosmetics
15.7.7.4.5.
Others
15.7.7.5.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
15.7.7.5.1.
Polymer
15.7.7.5.2.
Polydimethylsiloxane
(PDMS)
15.7.7.5.3.
Glass
15.7.7.5.4.
Silicon
15.7.7.5.5.
Others
15.7.7.6.
Southeast
Asia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.
Indonesia
15.7.7.6.2.
Thailand
15.7.7.6.3.
Malaysia
15.7.7.6.4.
Singapore
15.7.7.6.5.
Rest of
Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1.
Rest of
Asia Pacific Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
15.7.8.1.1.
Products
15.7.8.1.2.
Software
15.7.8.1.3.
Services
15.7.8.2.
Rest of
Asia Pacific Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
15.7.8.2.1.
Lung-On-Chip
15.7.8.2.2.
Heart-On-Chip
15.7.8.2.3.
Liver-On-Chip
15.7.8.2.4.
Intestine-On-Chip
15.7.8.2.5.
Kidney-On-Chip
15.7.8.2.6.
Skin-On-Chip
15.7.8.2.7.
Blood-Brain-Barrier-On-Chip
15.7.8.2.8.
Multi-organs-on-a-chip
15.7.8.2.9.
Others
15.7.8.3.
Rest of
Asia Pacific Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.3.1.
Toxicology
Research
15.7.8.3.2.
Drug
Discovery
15.7.8.3.3.
Molecular
Biology
15.7.8.3.4.
Disease
Modelling
15.7.8.3.5.
Food
Safety and Quality Testing
15.7.8.3.6.
Others
15.7.8.4.
Rest of
Asia Pacific Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
15.7.8.4.1.
Biopharmaceutical
Companies
15.7.8.4.2.
Academics
and Research Institutes
15.7.8.4.3.
Food and
Beverages
15.7.8.4.4.
Cosmetics
15.7.8.4.5.
Others
15.7.8.5.
Rest of
Asia Pacific Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of
Material
15.7.8.5.1.
Polymer
15.7.8.5.2.
Polydimethylsiloxane
(PDMS)
15.7.8.5.3.
Glass
15.7.8.5.4.
Silicon
15.7.8.5.5.
Others
15.8. Key Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Offerings
15.8.3. By Organ Type
15.8.4. By Application
15.8.5. By End-User
15.8.6. By Type Of Material
16. Middle East and Africa Organ On-Chip Market
Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn)
16.2. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By Offerings
16.2.1. Products
16.2.2. Software
16.2.3. Services
16.3. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By Organ Type
16.3.1. Lung-On-Chip
16.3.2. Heart-On-Chip
16.3.3. Liver-On-Chip
16.3.4. Intestine-On-Chip
16.3.5. Kidney-On-Chip
16.3.6. Skin-On-Chip
16.3.7. Blood-Brain-Barrier-On-Chip
16.3.8. Multi-organs-on-a-chip
16.3.9. Others
16.4. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Toxicology Research
16.4.2. Drug Discovery
16.4.3. Molecular Biology
16.4.4. Disease Modelling
16.4.5. Food Safety and Quality Testing
16.4.6. Others
16.5. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By End-User
16.5.1. Biopharmaceutical Companies
16.5.2. Academics and Research Institutes
16.5.3. Food and Beverages
16.5.4. Cosmetics
16.5.5. Others
16.6. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By Type Of Material
16.6.1. Polymer
16.6.2. Polydimethylsiloxane (PDMS)
16.6.3. Glass
16.6.4. Silicon
16.6.5. Others
16.7. Middle East and Africa Organ On-Chip Market
Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1.
Saudi
Arabia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.1.1.1.
Products
16.7.1.1.2.
Software
16.7.1.1.3.
Services
16.7.1.2.
Saudi
Arabia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
16.7.1.2.1.
Lung-On-Chip
16.7.1.2.2.
Heart-On-Chip
16.7.1.2.3.
Liver-On-Chip
16.7.1.2.4.
Intestine-On-Chip
16.7.1.2.5.
Kidney-On-Chip
16.7.1.2.6.
Skin-On-Chip
16.7.1.2.7.
Blood-Brain-Barrier-On-Chip
16.7.1.2.8.
Multi-organs-on-a-chip
16.7.1.2.9.
Others
16.7.1.3.
Saudi
Arabia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.3.1.
Toxicology
Research
16.7.1.3.2.
Drug
Discovery
16.7.1.3.3.
Molecular
Biology
16.7.1.3.4.
Disease
Modelling
16.7.1.3.5.
Food
Safety and Quality Testing
16.7.1.3.6.
Others
16.7.1.4.
Saudi
Arabia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.1.4.1.
Biopharmaceutical
Companies
16.7.1.4.2.
Academics
and Research Institutes
16.7.1.4.3.
Food and
Beverages
16.7.1.4.4.
Cosmetics
16.7.1.4.5.
Others
16.7.1.5.
Saudi
Arabia Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
16.7.1.5.1.
Polymer
16.7.1.5.2.
Polydimethylsiloxane
(PDMS)
16.7.1.5.3.
Glass
16.7.1.5.4.
Silicon
16.7.1.5.5.
Others
16.7.2. UAE
16.7.2.1.
UAE
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.2.1.1.
Products
16.7.2.1.2.
Software
16.7.2.1.3.
Services
16.7.2.2.
UAE
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
16.7.2.2.1.
Lung-On-Chip
16.7.2.2.2.
Heart-On-Chip
16.7.2.2.3.
Liver-On-Chip
16.7.2.2.4.
Intestine-On-Chip
16.7.2.2.5.
Kidney-On-Chip
16.7.2.2.6.
Skin-On-Chip
16.7.2.2.7.
Blood-Brain-Barrier-On-Chip
16.7.2.2.8.
Multi-organs-on-a-chip
16.7.2.2.9.
Others
16.7.2.3.
UAE
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.3.1.
Toxicology
Research
16.7.2.3.2.
Drug
Discovery
16.7.2.3.3.
Molecular
Biology
16.7.2.3.4.
Disease
Modelling
16.7.2.3.5.
Food
Safety and Quality Testing
16.7.2.3.6.
Others
16.7.2.4.
UAE
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.2.4.1.
Biopharmaceutical
Companies
16.7.2.4.2.
Academics
and Research Institutes
16.7.2.4.3.
Food and
Beverages
16.7.2.4.4.
Cosmetics
16.7.2.4.5.
Others
16.7.2.5.
UAE
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
16.7.2.5.1.
Polymer
16.7.2.5.2.
Polydimethylsiloxane
(PDMS)
16.7.2.5.3.
Glass
16.7.2.5.4.
Silicon
16.7.2.5.5.
Others
16.7.3. Egypt
16.7.3.1.
Egypt
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.3.1.1.
Products
16.7.3.1.2.
Software
16.7.3.1.3.
Services
16.7.3.2.
Egypt
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
16.7.3.2.1.
Lung-On-Chip
16.7.3.2.2.
Heart-On-Chip
16.7.3.2.3.
Liver-On-Chip
16.7.3.2.4.
Intestine-On-Chip
16.7.3.2.5.
Kidney-On-Chip
16.7.3.2.6.
Skin-On-Chip
16.7.3.2.7.
Blood-Brain-Barrier-On-Chip
16.7.3.2.8.
Multi-organs-on-a-chip
16.7.3.2.9.
Others
16.7.3.3.
Egypt
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.3.1.
Toxicology
Research
16.7.3.3.2.
Drug
Discovery
16.7.3.3.3.
Molecular
Biology
16.7.3.3.4.
Disease
Modelling
16.7.3.3.5.
Food
Safety and Quality Testing
16.7.3.3.6.
Others
16.7.3.4.
Egypt
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.3.4.1.
Biopharmaceutical
Companies
16.7.3.4.2.
Academics
and Research Institutes
16.7.3.4.3.
Food and
Beverages
16.7.3.4.4.
Cosmetics
16.7.3.4.5.
Others
16.7.3.5.
Egypt
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
16.7.3.5.1.
Polymer
16.7.3.5.2.
Polydimethylsiloxane
(PDMS)
16.7.3.5.3.
Glass
16.7.3.5.4.
Silicon
16.7.3.5.5.
Others
16.7.4. Kuwait
16.7.4.1.
Kuwait
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.4.1.1.
Products
16.7.4.1.2.
Software
16.7.4.1.3.
Services
16.7.4.2.
Kuwait
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
16.7.4.2.1.
Lung-On-Chip
16.7.4.2.2.
Heart-On-Chip
16.7.4.2.3.
Liver-On-Chip
16.7.4.2.4.
Intestine-On-Chip
16.7.4.2.5.
Kidney-On-Chip
16.7.4.2.6.
Skin-On-Chip
16.7.4.2.7.
Blood-Brain-Barrier-On-Chip
16.7.4.2.8.
Multi-organs-on-a-chip
16.7.4.2.9.
Others
16.7.4.3.
Kuwait
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.3.1.
Toxicology
Research
16.7.4.3.2.
Drug
Discovery
16.7.4.3.3.
Molecular
Biology
16.7.4.3.4.
Disease
Modelling
16.7.4.3.5.
Food
Safety and Quality Testing
16.7.4.3.6.
Others
16.7.4.4.
Kuwait
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.4.4.1.
Biopharmaceutical
Companies
16.7.4.4.2.
Academics
and Research Institutes
16.7.4.4.3.
Food and
Beverages
16.7.4.4.4.
Cosmetics
16.7.4.4.5.
Others
16.7.4.5.
Kuwait
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
16.7.4.5.1.
Polymer
16.7.4.5.2.
Polydimethylsiloxane
(PDMS)
16.7.4.5.3.
Glass
16.7.4.5.4.
Silicon
16.7.4.5.5.
Others
16.7.5. South Africa
16.7.5.1.
South
Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
16.7.5.1.1.
Products
16.7.5.1.2.
Software
16.7.5.1.3.
Services
16.7.5.2.
South
Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
16.7.5.2.1.
Lung-On-Chip
16.7.5.2.2.
Heart-On-Chip
16.7.5.2.3.
Liver-On-Chip
16.7.5.2.4.
Intestine-On-Chip
16.7.5.2.5.
Kidney-On-Chip
16.7.5.2.6.
Skin-On-Chip
16.7.5.2.7.
Blood-Brain-Barrier-On-Chip
16.7.5.2.8.
Multi-organs-on-a-chip
16.7.5.2.9.
Others
16.7.5.3.
South
Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.3.1.
Toxicology
Research
16.7.5.3.2.
Drug
Discovery
16.7.5.3.3.
Molecular
Biology
16.7.5.3.4.
Disease
Modelling
16.7.5.3.5.
Food
Safety and Quality Testing
16.7.5.3.6.
Others
16.7.5.4.
South
Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
16.7.5.4.1.
Biopharmaceutical
Companies
16.7.5.4.2.
Academics
and Research Institutes
16.7.5.4.3.
Food and
Beverages
16.7.5.4.4.
Cosmetics
16.7.5.4.5.
Others
16.7.5.5.
South
Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
16.7.5.5.1.
Polymer
16.7.5.5.2.
Polydimethylsiloxane
(PDMS)
16.7.5.5.3.
Glass
16.7.5.5.4.
Silicon
16.7.5.5.5.
Others
16.7.6. Rest of Middle East & Africa
16.7.6.1.
Rest of
Middle East & Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts,
By Offerings
16.7.6.1.1.
Products
16.7.6.1.2.
Software
16.7.6.1.3.
Services
16.7.6.2.
Rest of
Middle East & Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts,
By Organ Type
16.7.6.2.1.
Lung-On-Chip
16.7.6.2.2.
Heart-On-Chip
16.7.6.2.3.
Liver-On-Chip
16.7.6.2.4.
Intestine-On-Chip
16.7.6.2.5.
Kidney-On-Chip
16.7.6.2.6.
Skin-On-Chip
16.7.6.2.7.
Blood-Brain-Barrier-On-Chip
16.7.6.2.8.
Multi-organs-on-a-chip
16.7.6.2.9.
Others
16.7.6.3.
Rest of
Middle East & Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.6.3.1.
Toxicology
Research
16.7.6.3.2.
Drug
Discovery
16.7.6.3.3.
Molecular
Biology
16.7.6.3.4.
Disease
Modelling
16.7.6.3.5.
Food
Safety and Quality Testing
16.7.6.3.6.
Others
16.7.6.4.
Rest of
Middle East & Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts,
By End-User
16.7.6.4.1.
Biopharmaceutical
Companies
16.7.6.4.2.
Academics
and Research Institutes
16.7.6.4.3.
Food and
Beverages
16.7.6.4.4.
Cosmetics
16.7.6.4.5.
Others
16.7.6.5.
Rest of
Middle East & Africa Organ On-Chip Market Revenue (US$ Mn) and Forecasts,
By Type Of Material
16.7.6.5.1.
Polymer
16.7.6.5.2.
Polydimethylsiloxane
(PDMS)
16.7.6.5.3.
Glass
16.7.6.5.4.
Silicon
16.7.6.5.5.
Others
16.8. Key Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Offerings
16.8.3. By Organ Type
16.8.4. By Application
16.8.5. By End-User
16.8.6. By Type Of Material
17. Latin America Organ On-Chip Market Analysis
and Forecasts, 2022 - 2030
17.1. Overview
17.1.1. Latin America Organ On-Chip Market Revenue
(US$ Mn)
17.2. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Offerings
17.2.1. Products
17.2.2. Software
17.2.3. Services
17.3. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Organ Type
17.3.1. Lung-On-Chip
17.3.2. Heart-On-Chip
17.3.3. Liver-On-Chip
17.3.4. Intestine-On-Chip
17.3.5. Kidney-On-Chip
17.3.6. Skin-On-Chip
17.3.7. Blood-Brain-Barrier-On-Chip
17.3.8. Multi-organs-on-a-chip
17.3.9. Others
17.4. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Application
17.4.1. Toxicology Research
17.4.2. Drug Discovery
17.4.3. Molecular Biology
17.4.4. Disease Modelling
17.4.5. Food Safety and Quality Testing
17.4.6. Others
17.5. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By End-User
17.5.1. Biopharmaceutical Companies
17.5.2. Academics and Research Institutes
17.5.3. Food and Beverages
17.5.4. Cosmetics
17.5.5. Others
17.6. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Type Of Material
17.6.1. Polymer
17.6.2. Polydimethylsiloxane (PDMS)
17.6.3. Glass
17.6.4. Silicon
17.6.5. Others
17.7. Latin America Organ On-Chip Market Revenue
(US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1.
Brazil
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
17.7.1.1.1.
Products
17.7.1.1.2.
Software
17.7.1.1.3.
Services
17.7.1.2.
Brazil
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
17.7.1.2.1.
Lung-On-Chip
17.7.1.2.2.
Heart-On-Chip
17.7.1.2.3.
Liver-On-Chip
17.7.1.2.4.
Intestine-On-Chip
17.7.1.2.5.
Kidney-On-Chip
17.7.1.2.6.
Skin-On-Chip
17.7.1.2.7.
Blood-Brain-Barrier-On-Chip
17.7.1.2.8.
Multi-organs-on-a-chip
17.7.1.2.9.
Others
17.7.1.3.
Brazil
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.3.1.
Toxicology
Research
17.7.1.3.2.
Drug
Discovery
17.7.1.3.3.
Molecular
Biology
17.7.1.3.4.
Disease
Modelling
17.7.1.3.5.
Food
Safety and Quality Testing
17.7.1.3.6.
Others
17.7.1.4.
Brazil
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
17.7.1.4.1.
Biopharmaceutical
Companies
17.7.1.4.2.
Academics
and Research Institutes
17.7.1.4.3.
Food and
Beverages
17.7.1.4.4.
Cosmetics
17.7.1.4.5.
Others
17.7.1.5.
Brazil
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
17.7.1.5.1.
Polymer
17.7.1.5.2.
Polydimethylsiloxane
(PDMS)
17.7.1.5.3.
Glass
17.7.1.5.4.
Silicon
17.7.1.5.5.
Others
17.7.2. Argentina
17.7.2.1.
Argentina
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
17.7.2.1.1.
Products
17.7.2.1.2.
Software
17.7.2.1.3.
Services
17.7.2.2.
Argentina
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ Type
17.7.2.2.1.
Lung-On-Chip
17.7.2.2.2.
Heart-On-Chip
17.7.2.2.3.
Liver-On-Chip
17.7.2.2.4.
Intestine-On-Chip
17.7.2.2.5.
Kidney-On-Chip
17.7.2.2.6.
Skin-On-Chip
17.7.2.2.7.
Blood-Brain-Barrier-On-Chip
17.7.2.2.8.
Multi-organs-on-a-chip
17.7.2.2.9.
Others
17.7.2.3.
Argentina
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.3.1.
Toxicology
Research
17.7.2.3.2.
Drug
Discovery
17.7.2.3.3.
Molecular
Biology
17.7.2.3.4.
Disease
Modelling
17.7.2.3.5.
Food
Safety and Quality Testing
17.7.2.3.6.
Others
17.7.2.4.
Argentina
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
17.7.2.4.1.
Biopharmaceutical
Companies
17.7.2.4.2.
Academics
and Research Institutes
17.7.2.4.3.
Food and
Beverages
17.7.2.4.4.
Cosmetics
17.7.2.4.5.
Others
17.7.2.5.
Argentina
Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of Material
17.7.2.5.1.
Polymer
17.7.2.5.2.
Polydimethylsiloxane
(PDMS)
17.7.2.5.3.
Glass
17.7.2.5.4.
Silicon
17.7.2.5.5.
Others
17.7.3. Rest of Latin America
17.7.3.1.
Rest of
Latin America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Offerings
17.7.3.1.1.
Products
17.7.3.1.2.
Software
17.7.3.1.3.
Services
17.7.3.2.
Rest of
Latin America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Organ
Type
17.7.3.2.1.
Lung-On-Chip
17.7.3.2.2.
Heart-On-Chip
17.7.3.2.3.
Liver-On-Chip
17.7.3.2.4.
Intestine-On-Chip
17.7.3.2.5.
Kidney-On-Chip
17.7.3.2.6.
Skin-On-Chip
17.7.3.2.7.
Blood-Brain-Barrier-On-Chip
17.7.3.2.8.
Multi-organs-on-a-chip
17.7.3.2.9.
Others
17.7.3.3.
Rest of
Latin America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.3.1.
Toxicology
Research
17.7.3.3.2.
Drug
Discovery
17.7.3.3.3.
Molecular
Biology
17.7.3.3.4.
Disease
Modelling
17.7.3.3.5.
Food
Safety and Quality Testing
17.7.3.3.6.
Others
17.7.3.4.
Rest of
Latin America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By End-User
17.7.3.4.1.
Biopharmaceutical
Companies
17.7.3.4.2.
Academics
and Research Institutes
17.7.3.4.3.
Food and
Beverages
17.7.3.4.4.
Cosmetics
17.7.3.4.5.
Others
17.7.3.5.
Rest of
Latin America Organ On-Chip Market Revenue (US$ Mn) and Forecasts, By Type Of
Material
17.7.3.5.1.
Polymer
17.7.3.5.2.
Polydimethylsiloxane
(PDMS)
17.7.3.5.3.
Glass
17.7.3.5.4.
Silicon
17.7.3.5.5.
Others
17.8. Key Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Offerings
17.8.3. By Organ Type
17.8.4. By Application
17.8.5. By End-User
17.8.6. By Type Of Material
18. Competitive Benchmarking
18.1. Brand Benchmarking
18.2. Market Share Analysis, 2021
18.3. Global Presence and Growth Strategies
18.3.1. Mergers and Acquisitions
18.3.2. Product Launches
18.3.3. Investments Trends
18.3.4. R&D Initiatives
19. Player Profiles
19.1. AxoSim Inc.
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. BEOnChip
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. BiomimX S.r.l
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. CN Bio Innovations
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. Elveflow
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. Emulate Inc.
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. InSphero AG
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. Mesobiotech
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. Micronit
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. Mimetas BV
19.10.1. Company Details
19.10.2. Company Overview
19.10.3. Product Offerings
19.10.4. Key Developments
19.10.5. Financial Analysis
19.10.6. SWOT Analysis
19.10.7. Business Strategies
19.11. Nortis Inc.
19.11.1. Company Details
19.11.2. Company Overview
19.11.3. Product Offerings
19.11.4. Key Developments
19.11.5. Financial Analysis
19.11.6. SWOT Analysis
19.11.7. Business Strategies
19.12. Tara Biosystems
19.12.1. Company Details
19.12.2. Company Overview
19.12.3. Product Offerings
19.12.4. Key Developments
19.12.5. Financial Analysis
19.12.6. SWOT Analysis
19.12.7. Business Strategies
19.13. TissUse GmbH
19.13.1. Company Details
19.13.2. Company Overview
19.13.3. Product Offerings
19.13.4. Key Developments
19.13.5. Financial Analysis
19.13.6. SWOT Analysis
19.13.7. Business Strategies
19.14. Other Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.